Biotech Nipocalimab pivotal Phase 3 trial demonstrates longest sustained disease control in FcRn class for broadest population of myasthenia gravis patients June 29, 2024
Biotech Breakthrough in Tremor Treatment: Robotic Therapy Developed by GIST Researchers Improves Daily Activities June 29, 2024
Biotech O’Shaughnessy Ventures Awards $100,000 Fellowship Grant to Biotech Entrepreneur Aiming to Revolutionize Microbiome Health Monitoring June 29, 2024
Biotech CHMP Issues Negative Opinion on Translarna™ Following European Commission Request for Review June 28, 2024
Biotech CureLab Oncology Files Patent Application for Groundbreaking Wound-Healing Therapy June 27, 2024
Biotech Resolution Therapeutics Receives MHRA Approval to Commence Phase I/II EMERALD Study for Lead Candidate RTX001 June 27, 2024
Biotech Antengene Announces XPOVIO® (selinexor) National Health Insurance Service Approval for Reimbursement in South Korea June 26, 2024